chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19, VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included COVID-19 VACCINE (COVID 19 VACCINE (MANUFACTURER UNKNOWN)) for covid-19 prophylaxis.   On an unknown date, the patient received Shingles vaccine and COVID 19 VACCINE (MANUFACTURER UNKNOWN). On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient had vaccination for shingles and got Covid shot and 4 weeks got shingles. It was unknown if the reporter considered the shingles to be related to Covid-19 vaccine. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Incomplete course of vaccination, Pain
Clinical narrative: shingles; do hurt; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shingles and pain. On an unknown date, the outcome of the shingles and pain were unknown.   It was unknown if the reporter considered the shingles and pain to be related to Shingles vaccine.  Additional case details were reported as follows: The case was reported by patient. The age at vaccination was not reported. The patient had Shingles shot and broke out with shingles and they also hurt. The patient would not take the 2nd shot. No contact details were reported.
Sex: U
Vaccine: VARZOS
Symptoms: Incomplete course of vaccination
Clinical narrative: first injection Aug 19, 2018 / Get second injection now, three years later?; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix vaccine (1st dose received on 19th August 2018).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were reported as follows: This case was reported by the patient for himself or herself. The age at vaccination was not applicable. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The patient asked about dose schedule and questioned if the patient should get second injection now, three years later or start over with two-injection regimen. The reporter consented to follow up.
Sex: F
Vaccine: VARZOS
Symptoms: Recalled product administered
Clinical narrative: received the recall batch of Shingrix that GSK issued on 02/10/2021; received the recall batch of Shingrix that GSK issued on 02/10/2021; This case was reported by a other health professional via call center representative and described the occurrence of recalled drug administered in a 52-year-old female patient who received Herpes zoster (Shingrix) (batch number TT2JF, expiry date 28th October 2022) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced recalled drug administered and drug dispensing error. On an unknown date, the outcome of the recalled drug administered and drug dispensing error were unknown.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient received the recall batch of Shingrix that Glaxosmithkline issued on 10th February 2021. The reporter stated that, the lot number was not 9LH3Y and was not sure if this the lot number from one of the vials. The reporter stated that, the vaccine was administered to the patient before the recall of drug. This case was 1 of 8 linked cases, reported by same reporter for different patients. The reporter consented to follow up via email.
Sex: F
Vaccine: VARZOS
Symptoms: Recalled product administered
Clinical narrative: received the recall batch of Shingrix that GSK issued on 02/10/2021; received the recall batch of Shingrix that GSK issued on 02/10/2021; This case was reported by a other health professional via call center representative and described the occurrence of recalled drug administered in a 53-year-old female patient who received Herpes zoster (Shingrix) (batch number TT2JF, expiry date 28th October 2022) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced recalled drug administered and drug dispensing error. On an unknown date, the outcome of the recalled drug administered and drug dispensing error were unknown.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient received the recall batch of Shingrix that Glaxosmithkline issued on 10th February 2021. The reporter stated that, the lot number was not 9LH3Y and was not sure if this the lot number from one of the vials. The reporter stated that, the vaccine was administered to the patient before the recall of drug. This case was 1 of 8 linked cases, reported by same reporter for different patients. The reporter consented to follow up via email.
Sex: F
Vaccine: VARZOS
Symptoms: Recalled product administered
Clinical narrative: received the recall batch of Shingrix that GSK issued on 02/10/2021; received the recall batch of Shingrix that GSK issued on 02/10/2021; This case was reported by a other health professional via call center representative and described the occurrence of recalled drug administered in a 59-year-old female patient who received Herpes zoster (Shingrix) (batch number TT2JF, expiry date 28th October 2022) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced recalled drug administered and drug dispensing error. On an unknown date, the outcome of the recalled drug administered and drug dispensing error were unknown.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient received the recall batch of Shingrix that Glaxosmithkline issued on 10th February 2021. The reporter stated that, the lot number was not 9LH3Y and was not sure if this the lot number from one of the vials. The reporter stated that, the vaccine was administered to the patient before the recall of drug. This case was 1 of 8 linked cases, reported by same reporter for different patients. The reporter consented to follow up via email.
Sex: M
Vaccine: VARZOS
Symptoms: Recalled product administered
Clinical narrative: received the recall batch of Shingrix that GSK issued on 02/10/2021; received the recall batch of Shingrix that GSK issued on 02/10/2021; This case was reported by a other health professional via call center representative and described the occurrence of recalled drug administered in a 74-year-old male patient who received Herpes zoster (Shingrix) (batch number TT2JF, expiry date 28th October 2022) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced recalled drug administered and drug dispensing error. On an unknown date, the outcome of the recalled drug administered and drug dispensing error were unknown.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient received the recall batch of Shingrix that issued on 10th February 2021. The reporter stated that, the lot number was not 9LH3Y and was not sure if this the lot number from one of the vials. The reporter stated that, the vaccine was administered to the patient before the recall of drug. This case was 1 of 8 linked cases, reported by same reporter for different patients. The reporter consented to follow up via email.
Sex: M
Vaccine: VARZOS
Symptoms: Recalled product administered
Clinical narrative: received the recall batch of Shingrix that GSK issued on 02/10/2021; received the recall batch of Shingrix that GSK issued on 02/10/2021; This case was reported by a other health professional via call center representative and described the occurrence of recalled drug administered in a 80-year-old male patient who received Herpes zoster (Shingrix) (batch number TT2JF, expiry date 28th October 2022) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced recalled drug administered and drug dispensing error. On an unknown date, the outcome of the recalled drug administered and drug dispensing error were unknown.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient received the recall batch of Shingrix that Glaxosmithkline issued on 10th February 2021. The reporter stated that, the lot number was not 9LH3Y and was not sure if this the lot number from one of the vials. The reporter stated that, the vaccine was administered to the patient before the recall of drug. This case was 1 of 8 linked cases, reported by same reporter for different patients. The reporter consented to follow up via email.
Sex: M
Vaccine: VARZOS
Symptoms: Product dispensing error, Recalled product administered
Clinical narrative: received the recall batch of Shingrix that GSK issued on 02/10/2021; received the recall batch of Shingrix that GSK issued on 02/10/2021; This case was reported by a other health professional via call center representative and described the occurrence of recalled drug administered in a 58-year-old male patient who received Herpes zoster (Shingrix) (batch number TT2JF, expiry date 28th October 2022) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced recalled drug administered and drug dispensing error. On an unknown date, the outcome of the recalled drug administered and drug dispensing error were unknown.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient received the recall batch of Shingrix that Glaxosmithkline issued on 10th February 2021. The reporter stated that, the lot number was not 9LH3Y and was not sure if this the lot number from one of the vials. The reporter stated that, the vaccine was administered to the patient before the recall of drug. This case was 1 of 8 linked cases, reported by same reporter for different patients. The reporter consented to follow up via email.
Sex: F
Vaccine: VARZOS
Symptoms: Recalled product administered
Clinical narrative: received the recall batch of Shingrix that GSK issued on 02/10/2021; received the recall batch of Shingrix that GSK issued on 02/10/2021; This case was reported by a other health professional via call center representative and described the occurrence of recalled drug administered in a 74-year-old female patient who received Herpes zoster (Shingrix) (batch number TT2JF, expiry date 28th October 2022) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced recalled drug administered and drug dispensing error. On an unknown date, the outcome of the recalled drug administered and drug dispensing error were unknown.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient received the recall batch of Shingrix that Glaxosmithkline issued on 10th February 2021. The reporter stated that, the lot number was not 9LH3Y and was not sure if this the lot number from one of the vials. The reporter stated that, the vaccine was administered to the patient before the recall of drug. This case was 1 of 8 linked cases, reported by same reporter for different patients. The reporter consented to follow up via email.
Sex: F
Vaccine: MEN
Symptoms: Abdominal discomfort, Diarrhoea, Malaise, Muscle spasms, Nausea
Clinical narrative: diarrhea; horrible cramping; Nausea; Stomach issues; vomiting / throwing up; had to stay home from vacation because of it; This case was reported by a consumer via interactive digital media and described the occurrence of nausea in a female patient who received Men B NVS (Meningococcal B vaccine) for prophylaxis.   On 19th August 2021, the patient received Meningococcal B vaccine. In August 2021, less than a week after receiving Meningococcal B vaccine, the patient experienced feeling unwell. On 21st August 2021, the patient experienced nausea, stomach discomfort, vomiting and cramp. On 22nd August 2021, the patient experienced diarrhea. On an unknown date, the outcome of the nausea, stomach discomfort and feeling unwell were unknown and the outcome of the vomiting was recovered/resolved and the outcome of the diarrhea and cramp were not recovered/not resolved.   It was unknown if the reporter considered the nausea, stomach discomfort, vomiting, diarrhea, cramp and feeling unwell to be related to Meningococcal B vaccine.  Additional details provided were as follows: The case was reported by patient's mother. Age at vaccination was not reported. The patient's mother reported that the patient  received the dose of Meningococcal B vaccine on Thursday afternoon and on Saturday she experienced bad reactions including horrible cramping, stomach issues, nausea and vomiting and the next day she was able to keep food down but had diarrhea and cramping was still there. She had to stay home from vacation because of it. Follow-up would not be possible as no contact details available. Note- since the reporter provided details about vaccination day (Thursday) and onset of event (Saturday), so time to onset captured as per these details.
Sex: F
Vaccine: MEN
Symptoms: Vomiting
Clinical narrative: diarrhea; horrible cramping; Nausea; Stomach issues; vomiting / throwing up; had to stay home from vacation because of it; This case was reported by a consumer via interactive digital media and described the occurrence of nausea in a female patient who received Men B NVS (Meningococcal B vaccine) for prophylaxis.   On 19th August 2021, the patient received Meningococcal B vaccine. In August 2021, less than a week after receiving Meningococcal B vaccine, the patient experienced feeling unwell. On 21st August 2021, the patient experienced nausea, stomach discomfort, vomiting and cramp. On 22nd August 2021, the patient experienced diarrhea. On an unknown date, the outcome of the nausea, stomach discomfort and feeling unwell were unknown and the outcome of the vomiting was recovered/resolved and the outcome of the diarrhea and cramp were not recovered/not resolved.   It was unknown if the reporter considered the nausea, stomach discomfort, vomiting, diarrhea, cramp and feeling unwell to be related to Meningococcal B vaccine.  Additional details provided were as follows: The case was reported by patient's mother. Age at vaccination was not reported. The patient's mother reported that the patient  received the dose of Meningococcal B vaccine on Thursday afternoon and on Saturday she experienced bad reactions including horrible cramping, stomach issues, nausea and vomiting and the next day she was able to keep food down but had diarrhea and cramping was still there. She had to stay home from vacation because of it. Follow-up would not be possible as no contact details available. Note- since the reporter provided details about vaccination day (Thursday) and onset of event (Saturday), so time to onset captured as per these details.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Pain
Clinical narrative: shingles; painful; This case was reported by a consumer and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shingles, and pain. On an unknown date, the outcome of the shingles was not recovered/not resolved and the outcome of the pain was unknown.   It was unknown if the reporter considered the shingles and pain to be related to Shingles vaccine.  Additional details provided were age at vaccination was not reported. The patient self reported the case. The patient received 1st dose of Shingles vaccine and still had shingles which was very painful. The patient stated that he/she would be going back to get the two shots because he/she did not want them again. Follow-up would not be possible as no contact details provided.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Suspected Vaccination failure; gotten shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a n unspecified number of patients who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The reporter stated that, everyone they kne, who took the shingles jab had gotten shingles. Some of them got it twice. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization for shingles, time to onset for event and laboratory confirmation for herpes zoster were not provided. This case has been linked to US2021AMR180478, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR180478:Same reporter
Sex: U
Vaccine: VARZOS
Symptoms: Feeling abnormal, Pain, Pyrexia
Clinical narrative: fever; body aches; knocked me out; This case was reported by a consumer via interactive digital media and described the occurrence of fever in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced fever, general body pain and feeling abnormal. On an unknown date, the outcome of the fever, general body pain and feeling abnormal were unknown.   It was unknown if the reporter considered the fever, general body pain and feeling abnormal to be related to Shingles vaccine.  Additional details provided were as follows: Age at vaccination was not reported. The case was reported by patient himself/herself. The patient received 2nd dose which knocked him/her out and experienced fever and body aches. Follow-up would not be possible as no contact details available.
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media (suspected) and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: The patient self reported the case. The age at vaccination was not reported. The patient received all doses of shingles but got shingles, though not severe. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization for shingles, time to onset for event and laboratory confirmation for herpes zoster were not provided.
Sex: U
Vaccine: VARZOS
Symptoms: Injection site pain
Clinical narrative: had the shots, most painful shot I can ever remember having; This case was reported by a consumer and described the occurrence of injection site pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved.   It was unknown if the reporter considered the injection site pain to be related to Shingles vaccine.  Additional details were provided as the patient self reported this case. The age at vaccination was not reported. The patient got the 1st shingle shots and for some reason, it was the most painful shot he/she could ever remember.  The patient was glad that he/she did it though. For tolerance to 2nd dose, refer case US2021AMR180458. Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR180458: Same patient, different dose.
Sex: U
Vaccine: VARZOS
Symptoms: Injection site pain
Clinical narrative: had the shots, most painful shot I can ever remember having; This case was reported by a consumer via interactive digital media and described the occurrence of injection site pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of injection site pain (received 1st dose on an unknown date and experienced injection site pain, , for tolerance refer case US2021AMR180445).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced injection site pain. Rechallenge with Shingles vaccine was positive. On an unknown date, the outcome of the injection site pain was unknown.   It was unknown if the reporter considered the injection site pain to be related to Shingles vaccine.  Additional details were provided as follows: The patient self reported this case. The age at vaccination was not reported. The patient got the 2nd shingle shot and for some reason, it was the most painful shot he/she could ever remember. The patient was glad that he/she did it though.
Sex: U
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: rash; This case was reported by a consumer and described the occurrence of rash in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced rash. On an unknown date, the outcome of the rash was not recovered/not resolved.   It was unknown if the reporter considered the rash to be related to Shingles vaccine.  Additional details were provided as the patient self reported this case. The age at vaccination was not reported. The patient received Shingles vaccine and experienced since than had persistent rash. When the patient get to went away, then it pops up somewhere else. The reporter said It was terrible but still better than shingles. No contact details were reported. Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR180470, Same patient, different dose.
Sex: M
Vaccine: VARZOS
Symptoms: Groin pain, Herpes zoster, Rash, Vaccination failure
Clinical narrative: Suspected vaccination failure; got shingles three times. The worst one was in his groin; very very painful!; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.  Additional details were provided as follows: The patient's wife reported the case. The age at vaccination was not reported. The reporter stated that, the patient was not safe by getting the shot. The patient had the shot and after that he got shingles three times. The worst one was in his groin very very painful. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization for shingles, time to onset for event and laboratory confirmation for herpes zoster were not provided.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Suspected vaccination failure; gotten shingles and my cousin 3 times; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient was the reporter's cousin. The age at vaccination was not reported. The patient received the shot and got shingles 3 times. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization for shingles, time to onset for event and laboratory test confirming herpes zoster were not provided. This case has been linked to US2021AMR180429, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR180429:Same reporter
Sex: U
Vaccine: VARZOS
Symptoms: Condition aggravated, Herpes zoster, Incomplete course of vaccination
Clinical narrative: shingles, after having the first shingles shot; Didn't have the second; This case was reported by a consumer via  interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included chickenpox and shingles (had 2 times).   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and not applicable after receiving Shingles vaccine, the patient experienced shingles and incomplete course of vaccination. On an unknown date, the outcome of the shingles and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported for 1st dose and not applicable for 2nd dose. The patient received 1st dose of Shingles vaccine and experienced shingles. Till the time of reporting, the patient did not have the second shot, which led to incomplete course of vaccination. The patient was not for sure about everybody getting the shot. The follow-up would not possible as no contact details were available.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: shingles; This case was reported by a consumer and described the occurrence of shingles in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, less than a month after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were reported as the patient was reporter's mother. The age at vaccination was not reported. The patient received her shot and within weeks got shingles.
Sex: U
Vaccine: VARZOS
Symptoms: Pain
Clinical narrative: Painful; This case was reported by a consumer and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain. On an unknown date, the outcome of the pain was unknown.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.  Additional details were provided as the case was reported by the consumer for herself/himself. The age at vaccination was not reported. The patient stated that the 2nd shot of Shingles vaccine was painful as after effects.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Post herpetic neuralgia, Vaccination failure
Clinical narrative: Suspected Vaccination failure; I have phn; don't bet on it.. I had the vaccine.. snd I've been fighting this; This case was reported by a consumer via  interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and post herpetic neuralgia. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles and post herpetic neuralgia were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles and post herpetic neuralgia to be related to Shingles vaccine.  Additional details were provided as follows: The patient self reported this case. The age at vaccination was not reported. The patient had the shingles vaccine and had been fighting this for 6 months. The patient had post herpetic neuralgia. This case was considered as suspected vaccination failure since the details regarding completion of primary immunization schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Irritability
Clinical narrative: Even had them in my arm pits; Mild but drove me nuts; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shingles and feeling irritated. On an unknown date, the outcome of the shingles and feeling irritated were recovered/resolved.   It was unknown if the reporter considered the shingles and feeling irritated to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient himself/herself. The age at vaccination was not reported. The patient received the 1st dose of Shingles vaccine and patient stated that he/she had same reaction, mild but drove him/her nuts and even had shingles in arm pits, but it certainly beat having a bad case. The reporter stated that research said to get the second shot even though you reacted to the first. The reporter stated that absolutely no reaction to the 2nd shot.
Sex: U
Vaccine: VARZOS
Symptoms: Dermatitis acneiform, Pruritus, Rash
Clinical narrative: very itchy pimple like spot here and there on my body; pimple like spot; breakout; This case was reported by a consumer and described the occurrence of pruritus in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (received 1st dose on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, immediately after receiving Shingles vaccine, the patient experienced pruritus, pimple-like rash, and skin breakout. On an unknown date, the outcome of the pruritus, pimple-like rash, and skin breakout were not recovered/not resolved.   It was unknown if the reporter considered the pruritus, pimple-like rash and skin breakout to be related to Shingles vaccine.  Additional details were provided as the case was reported by patient. The age at vaccination was not reported. The patient had both shots and shortly after started a breakout know on head with a very itchy pimple like spot here and there on body. The patient stated that it had been almost 2 months. The patient asked if it was shingles.
Sex: U
Vaccine: VARZOS
Symptoms: Social problem
Clinical narrative: then COVID hit and I never got the other one; This case was reported by a consumer and described the occurrence of social problem in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (1st dose received 12 months ago from the date of reporting).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown.  Additional details were provided as the reporter was the patient. The age at vaccination was not applicable for this report. The pharmacist reported that, the patient did not receive 2nd dose of Shingrix due to COVID pandemic situation, which led to social problem. The reporter asked if need to restart again.
Sex: U
Vaccine: VARZOS
Symptoms: Malaise
Clinical narrative: terribly sick; This case was reported by a consumer and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown.   It was unknown if the reporter considered the sickness to be related to Shingles vaccine.  Additional details were provided as the case was reported by the patient. The age at vaccination was not reported. The patient got terribly sick after the second dose of Shingles vaccine.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: got it; This case was reported by a consumer and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were provided as the case was reported by the patient. The age at vaccination was not reported. The patient got shingles after the 1st shot of Shingles vaccine.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: I got them; This case was reported by a consumer and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were reported as the case was reported by the patient. The age at vaccination was not reported. The patient got them when he/she got the 1st shot too and the patient said did not think want to get another shot if it did not help as the patient going to get it anyway. No contact details were reported.
Sex: U
Vaccine: VARZOS
Symptoms: Pain in extremity
Clinical narrative: arm hurt; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included COVID-19 VACCINE UNKNOWN with an associated reaction of pain in extremity (received in 6 months ago from the date of reporting) and shingles vaccine (received on an unknown date).   On 26th August 2021, the patient received the 1st dose of Shingrix. On 26th August 2021, less than a day after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient had the older one 12 years ago from the date of reporting and just got the new one Thursday on the date of reporting. The arm hurt more on the Shingrix. No contact details were reported.
Sex: U
Vaccine: VARZOS
Symptoms: Incomplete course of vaccination, Social problem
Clinical narrative: could not get the 2nd due to covid; This case was reported by a consumer via call center representative and described the occurrence of social problem in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in late 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not applicable for this report. The pharmacist reported that, the patient did not receive 2nd dose of Shingrix due to COVID, which led to social problem. The reporter asked if need to restart again. This case was linked with case US2021AMR183067, reported same reporter for different patient.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR183067:Same reporter
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 7 months after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows The patient had reported for him/herself. The age at vaccination was not reported. The patient received the newest version of the shingles shots. 7 months after receiving Shingles vaccine, the patient got shingles. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization and laboratory confirmation were not provided.
Sex: U
Vaccine: VARZOS
Symptoms: Condition aggravated, Herpes zoster, Vaccination failure
Clinical narrative: Suspected vaccination failure; Shingles twice; This case was reported by a consumer via interactive digital mediaand described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.  The patient's past medical history included shingles (five flare ups).   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. The action taken with Shingles vaccine was unknown. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows The patient had reported for him/herself. The age at vaccination was not reported. The patient got Shingles vaccine after having five flare ups.  After receiving Shingles vaccine, the patient had shingles twice. The patient stated that, as with any virus you could get it again and suggested to not get stressed out. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation were not provided.
Sex: F
Vaccine: VARZOS
Symptoms: Feeling abnormal, Herpes zoster, Vaccination failure
Clinical narrative: suspected vaccination failure; got it; This case was reported by a consumer via interactive digital media  and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.  On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows The case was reported for the reporter's grandmother. The age at vaccination was not reported. After receiving Shingles vaccine, the patient got shingles. The patient was in misery for months. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation were not provided.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.  Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows The patient had reported for him/herself. The age at vaccination was not reported. After receiving Shingles vaccine, the patient still got shingles. The patient had been told that happened and in a few cases, people got them more than once. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation were not provided.    This case had been linked with case US2021AMR183108, reported by the same reporter.
Sex: F
Vaccine: VARZOS
Symptoms: Inappropriate schedule of product administration, Social problem
Clinical narrative: could not get the 2nd due to covid; This case was reported by a consumer via call center representative and described the occurrence of social problem in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in late 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown.  Additional details were provided as follows: The reporter was the patient's husband. The age at vaccination was not applicable for this report. The pharmacist reported that, the patient did not receive 2nd dose of Shingrix due to COVID, which led to social problem. The reporter asked if need to restart again. This case was linked with case US2021AMR183042, reported same reporter for different patient.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR183042:Same reporter
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media  and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.  On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows The case was reported for the reporter's father. The age at vaccination was not reported. the patient received Shingles vaccine in his 70s. The patient never had the shingles until he received Shingles vaccine. Afte receiving Shingles vaccine, the patient got shingles. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation were not provided.